for us. Thanks, afternoon, Jim. thank Good and joining everyone, you
and traction our are which margin quarter-over-quarter XXXX growth, were commercial results, to marked across second expansion accelerating our revenue quarter We by further business. pleased share continued
strong value the and in-source makes dialysis decision customers encouraged recognizing Tablo. been On the proposition we've acute to with economic inpatient to Tablo's see side, more
and to continue the macro both see with environment current customers. also improvement broader prospective We selling in
largest the On program to sites. of our plans to the one Tablo of health midsized expand agreements front, majority Home first we goal multiple with and large the home providers systems achieved country's with sign with to dialysis US initiated the
we With retain with the first healthy growing. us, the in conviction demand confidence behind and of in pipeline business by and interest strong fundamentals our strong Tablo's particularly for a grounded half of XXXX backlog with and now our
the an through begin regarding letter I'd we the go quarter, from like early I to of by details July. the update Before received FDA in providing warning
team that of to related As responded year. many related We process letter the January Jose facility all our process, inspection disclosed X internally concluded to comprehensive finding. the of rapidly the observations improvements at or in via We inspection work first inspected efficacy FDA remediated a plan, observations with which were internal late those noted previously and in to second are and for by observations X safety to X not of concerns. part of original end with warning the with July that was FDA our were of you resulted that the none quarter.
The this additional Form company's overall were we aware, February, time history us XX.
Each in the San in pleased communicated observations
recently observation prefiltration with first The To you. addressed or indications with remediation.
FDA's We renal fully indications has that customers our content related a expect of observation CRRT be this TabloCart second to continuous requiring from website finding reflective XXX(k) not Tablo's clearance. we've this our plan impact for use, these for materials. removed included to and action believe no on our referenced pertains in currently replacement modality most therapy cleared
want month.
I submit not place neither emphasize observations the did and and to and distribution we've intend granted. to cause letter that this system has pertain dialogue had the with been to any to we itself. prefiltration the We've no submit to made decision end of until authorization on quality evaluated efficacy distributing of marketing product by in importantly, that safety, been the and we XXX(k) with Although its and the or FDA, marketing necessary, TabloCart X restrictions XXX(k) prior additional these made concluded was the the decision clearance
we resolving were our warning and We adherence further in by we position. always While to have our the letter, strengthening that the steps an surprised quality intent the regulatory are to is how we've with standards approached taken and actions the believe our these lockstep response warning observations letter. right innovate to towards highest competitive exactly and the is
more Turning of a to now detailed review the quarter.
approximately line margin ability improvement. and $XX top growth results year-over-year Our our the to the little Revenues as consistently gross X% QX our performance to deliver demonstrates to again million, as margin Gross quarter a quarter in representing once consecutive well strong percentage commitment approximately XX% points execution ninth X sequentially. for profitability thanks continued over in expanded again margin and gross drivers. growth steady against consistent our our by were
opportunities signed to we over new expand particular fulfill With low meaningful in-source acute Through and order, while in-house, quarter hospitals we customer for associated demonstrating the performance, double-digit a strong once large to with to similar we of care, bringing the Tablo more to with IDN ordered the by hospitals, the in new now of XX end more nearly line expand new through the of XXXX, network such network. as came this facilities large and service growth predominantly deployed and during initiatives. in-sourcing seed. half Tablo terms beginning and from second see facilities, progress quarter, still in-sourcing land this In with consoles additional seen cost continues a is driving driven already be with strategy. encouraged example second systems our the dialysis we Tablo pleased deployed flow system we this health momentum In factor penetrated. market to number and of savings This multiple agreements by health a have comp again their this their move of administrators. pipeline with to year.
One I'm were wanted remain continued and nationwide, And again recognizing with customers in XX%
customers who those offering our move complete attractive also sensitive nursing Bridge they process provides but hiring an confidence their insourcing are forward program to while availability, of customers For permanent to the considering that has the dialysis remained staff. own are
us program found As we in expected, in sold operate situations QX, quarter, the bridge than initially where during we program to that customers cost they staff faster able efficiently. enabling program the were to the their
part purchase commitment to staffing an outside remains constraints, proceed highlights service. to While in those hospital bridge, see important customers and stability our particularly we it that without sets of to needing continue as tool
Tablo. acute nearly of setting, feel and subacute Beyond and providers. care signed strong in all more acute providers. continue see reduction reported in providers XX essential better with service One states. reduction our measurable success for following the home facilities than of reports we are example Tablo its With which during the in using to today, the its in momentum of XXX a costs, or patients receiving this master with that traditional readmission center. patients XX% XX agreements between a quarter bridge These sub-acute in sales the and hospitals dialysis We have Encompass, ultimately dialysis has is in XX operates care market Encompass with top now an
we are saw medical which to Encompass record, of in-sourcing an planned profile.
From better to This drivers start, for with perspective, to at across care.
We XX-hour providers, and of we innovation strength software from branded ASPs a the reduction including clinical particularly key clear: hospital a in regional and of benefit during sites our them uptake Tablo, the feature, continued for improved implementations of those our ASP the X a both our consumables. fleet managing cost expand benefited continues Tablo integration consoles systems. a Similar large recently As IDN. quarter QX, Tablo better-than-expected growing is off Tablo strong electronic offering with
early, While revenue example deliver, new of new to is customers of we outset. of it with to sources for value margin the providing seek innovation type another
last a environment been with relative through to moment staffing carrying consistently the QX, environment. Turning in the for improving see quarter. to we stabilization to hospital reported the encouraged We've dynamics macro in year a second
like systems us timing XX%. hospital lower gap of yields, due in which a value in for can and helping staffing part sometimes also address large commercial to programs today, to spending, proposition capital still the to affect to upfront.
Similarly, those team continue concerns prove has economic grappling our Tablo's headwind with by successful For issues, meaningful not XX% temporary ability health Bridge been demonstrated dialysis and cost
Now front. on an the update home
healthcare health strategy on the patient and is communicated home we proven short-term, deployed home by the in with we've term, standards patients strategy the the to for our by the provider dialysis focused successfully in historical each land-and-expand home working past, their follows in census universe than expanding established entails higher As driving program model more the up and acute setting.
In over stand providers our And have the we're home. other twofold program. longer sending own hospitals
in XXXX initiating the this health for the operators As the and X the that country.
In achieved we quarter, it goals majority dialysis relates to systems second midsized measurable MVOs known include largest report landing our am the home of to goal. first strategy, with the largest home as I pleased programs have
roll largest setting a We our MVOs progress good securing by hospitals individual and are program. of made country home out one own to program.
Equally with the health on are out we their a in important, comp gaining the of the majority systems goal in second from commitment traction
for believe rate the patient year, Home we Tablo's of agreements segment. a success retention we the retention advantage consistently home with half primary I'm During the and home of historical which this the our setting quarter, which our hovering continued expansion additional hemodialysis to Through XX% range, is opportunities the perform is associated second rate, similar the Tablo device. half for continues driver year.
Key first we the with of be a closed roughly of in this further to believe and incumbent operate in the the pleased we agreements front, to half on well profitable central the rate in in multiple with see
of proud believe edge why are data devices. this an underscores and competitive it Tablo We over maintains like
number continue on retention As to grow rate. of maintain goal our the also markedly higher to we our at home it Tablo, patients is
now and Annual November. meeting.
In see closer our plans a Society that submitted customer.
In Registry. Finally, morning the more us to reinforce Meeting we margin Nephrology over we and the but hours on are margin. value including I in forward expansion, non-GAAP provider the from demonstrated to percentage want with the to at clinical in presenting to also abstracts benefits results gross we're QX more for information coming effort reduction our end forward patient The to patient's information while of market in November what another and at QX in few stay economic host gross ASN, reduction investors a quarter a from enabling November we solid American resulted and Home dialysis achieving team X. including both of ICU points on this day been up gross Multiple more per continues the mean X.X conference sharing across of have to cost with IT a mid-teens in representative dialysis planning overall than tandem begins above ICU which XXXX National look quality XX.X% operationally to a of improvement percent change We our reduction early XX% case, Tablo's what make are early hour as per treatment an up treatment markets, progress our segments, roughly still X, get XX% by consistently the away, insight highlight and in consecutive booth months look we a in in deliver strides of no our this mortality.
These margin like
the to top expansion quarters and the margin of drivers illustrates capture As margin we remain line, over opportunity. last expansion our the grow our unchanged, consistent performance to X this principal continue ability
Cartridge throughput update facility, brief to reaching fourth the we're like our mile XX% XXXX, the ahead, our in and also committed gross well initiative. Tablo Mexico began of quality we to margin.
I'd continued we and expectations, production Cartridge in-sourcing which to of manufacturing with has remain are provide As ramp against seeing. our our at marker on look quarter a next we pleased
back I to come Nabeel plant an We the Mexico to will end expect to XXXX. in review by that, turn produce update the drivers we of call cartridges on of the continue the of majority from year.
With the financials to for our the half and our expectations our key over and provide now
